Biomedical Engineering Reference
In-Depth Information
[158]
Agou, F., Courtois, G., Chiaravalli, J. et al., Inhibition of NF-kappaB activation by
peptides targeting NF-kappaB essential modulator (
nemo
) oligomerization,
J. Biol.
Chem.,
279, 54248, 2004.
[159]
Lin, Y.Z., Yao, S.Y., Veach, R.A. et al., Inhibition of nuclear translocation of tran-
scription factor NF-kappaB by a synthetic peptide containing a cell membrane-
permeable motif and nuclear localization sequence,
J. Biol. Chem.,
270, 14255, 1995.
[160]
Torgerson, T.R., Colosia, A.D., Donahue, J.P. et al., Regulation of NF-kappaB, AP-
1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of
peptide carrying the nuclear localization sequence of NF-kappaB p50,
J. Immunol.,
161, 6084, 1998.
[161]
Takada, Y., Singh, S., and Aggarwal, B.B., Identification of a p65 peptide that selec-
tively inhibits NF-kappaB activation induced by various inflammatory stimuli and its
role in down-regulation of NF-kappaB-mediated gene expression and up-regulation
of apoptosis,
J. Biol. Chem.,
279, 15096, 2004.
[162]
Morishita, R., Tomita, N., Kaneda, Y. et al., Molecular therapy to inhibit NF-kappaB
activation by transcription factor decoy oligonucleotides,
Curr. Opin. Pharmacol.,
4,
139, 2004.
[163]
Karagiannis, T.C. and El Osta, A., RNA interference and potential therapeutic appli-
cations of short interfering RNAs,
Cancer Gene Ther.
, 12, 787-795, 2005
.
[164]
Desmet, C., Gosset, P., Pajak, B. et al., Selective blockade of NF-kappaB activity in
airway immune cells inhibits the effector phase of experimental asthma,
J. Immunol.,
173, 5766, 2004.
[165]
Guo, J., Verma, U.N., Gaynor, R.B. et al., Enhanced chemosensitivity to irinotecan
by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65
subunit,
Clin. Cancer Res.,
10, 3333, 2004.
[166]
Pinkenburg, O., Platz, J., Beisswenger, C. et al., Inhibition of NF-kappaB mediated
inflammation by siRNA expressed by recombinant adeno-associated virus,
J. Virol.
Methods,
120, 119, 2004.
[167]
Takaesu, G., Surabhi, R.M., Park, K.J. et al., TAK1 is critical for IkappaB kinase-
mediated activation of the NF-kappaB pathway,
J. Mol. Biol.,
326, 105, 2003.
[168]
Ducut Sigala, J.L., Bottero, V., Young, D.B. et al., Activation of transcription factor
NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit,
Science,
304, 1963,
2004.
[169]
Silverman, N. and Maniatis, T., NF-kappaB signaling pathways in mammalian and
insect innate immunity,
Genes Dev.,
15, 2321, 2001.
[170]
Silverman, N., Zhou, R., Erlich, R.L. et al., Immune activation of NF-kappaB and
JNK requires
Drosophila
TAK1,
J. Biol. Chem.,
278, 48928, 2003.
[171]
Zhou, R., Silverman, N., Hong, M. et al., The role of ubiquitination in
Drosophila
innate immunity,
J. Biol. Chem.
, 280, 34048-55, 2005
.
[172]
Correa, R.G., Tergaonkar, V., Ng, J.K. et al., Characterization of NF-kappaB/IkappaB
proteins in zebra fish and their involvement in notochord development,
Mol. Cell
Biol.,
24, 5257, 2004.
[173]
Correa, R.G., Matsui, T., Tergaonkar, V. et al., Zebrafish IkappaB kinase 1 negatively
regulates NF-kappaB activity,
Curr. Biol.,
15, 1291, 2005.
[174]
Kapp, E. and Ghosh, S., Inhibition of NF-κB by sodium salicylate and aspirin,
Science,
265, 956, 1994.
[175]
Jimi, E., Aoki, K., Sairo, H. et al., Selective inhibition of NF-κB blocks osteoclas-
togenesis and prevents inflammatory bone destruction,
in vivo, Nature Med.,
10, 617,
2004.